OGT and COVID-19: As the occurrence of cardiovascular events during COVID-19 suggests that targeting the endothelium is part of the viral infection course, we surmise COVID-19 patients who have a pre-existing genetic propensity for low SON, OGT, and RORA expression may therefore be more susceptible to cardiac damage.